Fisher & Paykel Healthcare Corp. Ltd. | |
Stock Exchange | Australian Stock Exchange |
EPS |
AUD0.34 |
Market Cap |
AUD8.89 B |
Shares Outstanding |
572.67 M |
Public Float |
- |
Fisher & Paykel Healthcare Corp. Ltd. | |
Stock Exchange | New Zealand Stock Exchange |
EPS |
NZD0.36 |
Market Cap |
NZD9.34 B |
Shares Outstanding |
573.81 M |
Public Float |
571 M |
Address |
15 Maurice Paykel Place Auckland AU 2013 New Zealand |
Employees | - |
Website | http://www.fphcare.com |
Updated | 07/08/2019 |
Fisher & Paykel Healthcare Corp. Ltd. engages in the designing, manufacturing and marketing of medical device products and systems for use in respiratory care, acute care and the treatment of obstructive sleep apnea. It operates through the following segments: New Zealand, North America, Europe, and Asia-Pacific. New Zealand segment includes all activities controlled by entities or employees based in New Zealand, principally research and development, manufacturing, marketing, sales and distribution and administration. |